Battling against the Coronavirus Disease 2019

© 2021 by the Authors. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )

Download PDF

Cite

XML

References

[1]

Motohashi, N.; Vanam, A.; Gollapudi, R. In Silico Study of Curcumin and Folic Acid as Potent Inhibitors of Human Transmembrane Protease Serine 2 in the Treatment of COVID-19. INNOSC Theranos. Pharmacol. Sci., 2020, 3(2), 3–9.

[2]

Wu, S.; Sun, P.; Li, R.; Wang, Y.; Jiang, L.; Deng J. Epidemiological Model for COVID-19 in China. INNOSC Theranos. Pharmacol. Sci., 2020, 3(2), 10–7.

[3]

Mendonça, A.; Santos, C.; Pinto, I.C. Community Pharmacy Services during the COVID-19 Pandemic: A Systematic Review. INNOSC Theranos. Pharmacol. Sci., 2020, 3(2), 18–26.

[4]

Del Prado, M.E.; Ruiz-Villaverde, R.; Giavedoni, P.; Rodríguez,A.; Vidal, D.; Roustán, G.; Queipo, F.; Aneiros-Fernandez, J.; del Castillo, P.; Ruiz, E.; Moysset, I.; Suarez, L.; Najera, L.; Alfajeme, F. Skin Ultrasound as a Diagnostic Approach for Non-melanocytic Benign Skin Tumors. INNOSC Theranos. Pharmacol. Sci., 2020, 3(2), 27–37.

Previous article in this issue

Next article in this issue

INNOSC Theranostics and Pharmacological Sciences, Electronic ISSN: 2705-0823, Published by AccScience Publishing